Hanssar Chacón serves as Senior Director, Pharmacovigilance (PV) Operations at Hemab. He has over 20 years of progressive experience as a PV operational and regulatory compliance leader in biotech/ biopharma (Otsuka Pharmaceuticals,  International Partnership for Microbicides, MedImmune/AstraZeneca, Novavax, REGENXBIO, CRISPR Therapeutics). Hanssar has experience supporting global studies spanning clinical phases 1-3 for programs that range from small molecules to gene therapies, as well as managing postmarket surveillance operations and pharmacovigilance agreements with business partners.  He earned a Bachelor and Master of Science in Health Sciences degrees in Clinical Research Administration from The George Washington University in Washington, DC.